Kirkland & Ellis and Norton Rose Fulbright have advised Sterling Investment Partners and XKIG. Sterling Investment Partners has completed a recapitalization of XKIG through its first...
Sterling Investment Partners Closes Recapitalization of XKIG Through Continuation Vehicle
Centerbridge Partners to Acquire MeridianLink in $2 Billion All-Cash Transaction
Kirkland & Ellis has advised Centerbridge Partners, and Goodwin Procter has advised MeridianLink. Skadden has advised Thoma Bravo, MeridianLink, Inc.’s largest shareholder. Paul Hastings LLP represented...
Crown Laboratories’ $924 Million Merger with Revance Therapeutics
Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
Eli Lilly’s $2.4 Billion Pending Acquisition of DICE THerapeutics
Fenwick & West LLP represented DICE Therapeutics, Inc. in the transaction, while Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY)...
Apax Partners’ Recapitalization of Magaya Corporation
Kirkland & Ellis advised Apax Partners on the operation. Magaya Corporation announced that funds advised by Apax Digital, the growth equity arm of global private equity advisory...
Paradigm Precision’s Merger With Whitcraft Group
Debevoise & Plimpton advised CD&R, Kirkland & Ellis advised Whitcraft and Greenbriar, Latham & Watkins advised Paradigm and Carlyle on the deal. Clayton, Dubilier & Rice...
KKR’s Acquisition of Boasso Global
Simpson Thacher advised KKR, while Kirkland & Ellis and Houthoff advised Funds advised by Apax Partners on the deal. KKR announced its definitive agreement to acquire...
RapidRatings’ $200 Million Growth Investment
Kirkland & Ellis and Bryan Cave acted as legal advisors to RapidRatings. Latham & Watkins acted as legal advisors to Spectrum Equity and Sidley Austin acted...